HCPCS code Q4156 – Neox 100 or clarix 100

Key takeaways

HCPCS code Q4156 identifies Neox 100 or Clarix 100, a bioengineered skin and soft tissue substitute billed per square centimeter.

Q4156 must always be paired with a CPT application code from the 15271-15278 series on the same claim. Submitting Q4156 alone results in denial.

Since January 1, 2026, Medicare pays Q4156 as an incident-to supply at $127.14 per square centimeter, replacing the retired high-cost and low-cost split.

Only skin substitutes licensed as biologics under Section 351 still use the older ASP-based payment method.

Pabau’s claims management software supports wound care billers in tracking HCPCS codes, capturing required documentation, and submitting clean claims.

What is HCPCS code Q4156?

HCPCS code Q4156 is a Level II alphanumeric code for a bioengineered skin and soft tissue substitute applied to a wound. The Centers for Medicare and Medicaid Services (CMS) maintains it as part of the annual HCPCS update cycle. Unlike CPT codes that describe the procedure performed, Q4156 describes the specific skin substitute product itself. The application procedure is reported separately using a companion CPT code.

Q-codes in the HCPCS Level II system are temporary codes assigned by CMS to capture items and services not adequately described by CPT. Skin substitute Q-codes like Q4156 are product-specific, meaning each code maps to a particular manufacturer’s product or product line, not to a generic product category.

What product does Q4156 represent?

Q4156 represents Neox 100 or Clarix 100, cryopreserved human amniotic membrane allografts made by BioTissue. Both are regulated by the FDA as Section 361 human cells, tissues, and cellular and tissue-based products, or HCT/Ps. That regulatory pathway now determines how Medicare pays for the product, so it belongs in your charge master alongside the code itself.

These products are typically indicated for wounds that have not responded to conventional wound care over a defined treatment period. The most common qualifying wound types for skin substitute Q-codes under Medicare include:

• Diabetic foot ulcers (DFUs) that fail to respond to standard wound care
• Venous leg ulcers (VLUs) with documented treatment history
• Pressure injuries in select clinical circumstances
• Wounds related to peripheral arterial disease where clinically appropriate

CMS assigns individual Q-codes to specific manufacturer products. Coders must confirm that the product applied in the encounter is the one described by Q4156. Applying a different skin substitute product and billing Q4156 is a coding error regardless of clinical similarity. A practice adding wound care to an existing service line should build product-to-code verification into its charge capture process.

Medicare coverage and eligibility for Q4156 skin substitute billing

Medicare covers bioengineered skin substitute application, including Q4156, when medical necessity criteria are met. Coverage is not automatic, and the criteria vary by Medicare Administrative Contractor (MAC) jurisdiction.

The national framework sets the structure. Individual MACs specify which wound types qualify, how long prior standard wound care must have been documented, and what clinical findings trigger eligibility.

Common Medicare eligibility criteria for skin substitute application include:

• Wound present for a minimum of 30 days despite conventional treatment
• Full-thickness wound of qualifying type (DFU, VLU, or another wound type named in MAC policy)
• Adequate vascular supply documented
• Absence of wound infection at time of application
• Wound dimensions documented in the medical record

Coverage policy shifted at the end of 2025. On December 24, 2025, the A/B MACs withdrew the skin substitute Local Coverage Determinations for diabetic foot ulcers and venous leg ulcers. Those policies had been scheduled to take effect on January 1, 2026, and would have sharply narrowed the list of covered products.

Coverage now rests on each MAC’s remaining policy and on general Medicare medical necessity rules. CMS has not said what will replace the withdrawn policies, so check your MAC’s current coverage articles before billing Q4156. Relevant MACs include Novitas Solutions, CGS Administrators, Palmetto GBA, and WPS Government Health Administrators, each with jurisdiction over specific US states.

Covered ICD-10-CM diagnosis codes for Q4156 claims

Every Q4156 claim requires a supporting ICD-10-CM diagnosis code that establishes medical necessity. A code that lacks the required specificity, such as one missing laterality or wound depth, is a common denial trigger. Our ICD-10-CM code library carries the full descriptors when you need to check one. The following table shows representative ICD-10-CM codes accepted by Medicare for skin substitute claims:

Coders should always use the highest level of specificity available. Where laterality is required (right vs. left), using an unspecified code when the chart clearly documents a specific limb is a shortcut that auditors flag. Verify accepted ICD-10-CM codes against your MAC’s current coverage articles, as covered code lists are updated annually.

How Medicare pays for Q4156 in 2026

Medicare pays for Q4156 as an incident-to supply, not as a drug or biological. CMS finalized that change in the CY2026 Physician Fee Schedule final rule (CMS-1832-F). The OPPS and ASC final rule made the matching change, and both took effect on January 1, 2026.

The policy covers the physician office under the PFS non-facility rate. It also covers the hospital outpatient department under the Outpatient Prospective Payment System (OPPS).

The rate is a single national figure of $127.14 per square centimeter before geographic adjustment. CMS published $127.28 in the final rule, then corrected it to $127.14 in a notice issued on November 28, 2025. Your paid amount will differ from that figure once your locality’s geographic adjustment is applied.

Products are now grouped by FDA regulatory pathway rather than by cost tier. OPPS assigns each group its own ambulatory payment classification (APC), and all three carry the same CY2026 rate. CMS has said it intends to propose different rates for the three groups in later years.

Q4156 falls in the Section 361 HCT/P group, so it is paid at the incident-to supply rate in both settings. Only products licensed as biologics under Section 351 of the Public Health Service Act keep the older ASP-based method. That exception is narrow, and it does not cover Neox 100 or Clarix 100.

Two older rules went away with this change. CMS retired the high-cost and low-cost classification for products outside the Section 351 pathway, so there is no annual tier list to check for Q4156. CMS also deleted the low-cost application codes C5271 through C5278 as of December 31, 2025. The 15271 through 15278 application codes now apply in every setting.

If your charge master or payer policy still sorts skin substitutes into high-cost and low-cost buckets, it is running on pre-2026 logic. Claims built that way will not match how Medicare now prices the product.

CPT codes used with HCPCS code Q4156

Every Q4156 claim requires a paired CPT application code on the same date of service. The CPT code describes the procedure performed (applying the skin substitute), while Q4156 identifies the product used. Submitting Q4156 without a companion CPT code will result in claim denial.

Two facts about the wound pick the code: where it sits, and how much surface area it covers in total. The grid below pairs each combination with its base code and its add-on.

Diabetic foot ulcers typically map to 15275 for the foot, or to 15271 for a leg wound depending on its location. Document wound size in square centimeters in the procedure note. That measurement drives both the CPT selection and the number of add-on codes reported.

Do not read 15273, 15274, 15277, and 15278 as pediatric-only codes. They apply to any patient once total wound surface area reaches 100 sq cm. The percentage-of-body-area unit is only the alternate way to report them for infants and children. Reference the AAPC HCPCS code lookup when you need to verify a descriptor.

Billing HCPCS code Q4156 in HOPD vs. non-facility settings

Where the skin substitute is applied determines the claim form used, the payment rate applied, and which entity bills Medicare. HOPD and non-facility (physician office) billing follow different rules for Q4156. Mixing them up is one of the most common compliance errors in wound care billing. Check the current-year CMS Physician Fee Schedule for non-facility payment rates.

In an HOPD setting, the hospital bills the facility component on the UB-04. The treating physician may bill the professional component separately under the PFS using CMS-1500. The C5271 through C5278 application codes no longer exist, so hospital outpatient claims use the same 15271 through 15278 series as the office.

In a non-facility setting the charge slip has to capture both the Q-code and the CPT code, so both reach the CMS-1500. Missing either causes denial.

Documentation requirements for Q4156 skin substitute claims

Medicare’s documentation requirements for skin substitute claims are among the most detailed in wound care billing. Missing even one required element is enough for a claim to be denied or flagged during an audit. Compliance here starts with complete documentation before the claim is submitted, rather than after a denial arrives.

Required documentation for Q4156 claims typically includes:

• Wound measurements: Length x width x depth in centimeters, documented at each encounter
• Wound type and diagnosis: Clearly documented wound etiology matching the ICD-10-CM code billed
• Duration of wound: Date of wound onset, confirming the wound has been present for the required period (often 30+ days)
• Prior treatment history: Documentation of standard wound care already attempted and failed
• Product identification: Name of the specific skin substitute product applied and its lot number
• Units applied: Square centimeters of product applied, supporting CPT code selection
• Vascular assessment: Evidence of adequate perfusion where the MAC requires it
• Wound photographs: Some MACs require photographic documentation at baseline and subsequent visits
• Frequency and number of applications: Medicare limits the number of applications; each application must be medically necessary

A clean claim submission for Q4156 depends on having each of these elements in the patient record before the claim goes out. Retro-documentation after a denial is flagged as a compliance risk during audits. Standardized digital encounter forms are the simplest way to capture these fields consistently.

Keep record retention HIPAA-compliant for every wound care encounter. Medicare may request records going back several years during a Targeted Probe and Educate (TPE) review. Complete documentation from the original encounter is the primary defense against recoupment.

Common Q4156 denial reasons and how to prevent them

Most Q4156 denials trace back to a small set of repeat causes. Each one is preventable at charge capture rather than at appeal, which is where the time and the write-offs usually go.

Denials in this category are usually systemic rather than one-off. If the same reason code keeps appearing, fix the charge capture template instead of writing more appeals.

Related HCPCS skin substitute Q-codes

Q4156 belongs to a large family of skin substitute Q-codes updated annually by CMS. Coders who work with wound care practices frequently need to identify the correct Q-code for the specific product applied. The following table shows selected related Q-codes in the bioengineered skin substitute category:

Always confirm the active status of any skin substitute Q-code before billing. CMS deletes and replaces codes annually, and billing a deleted code results in automatic rejection. The CMS HCPCS overview and quarterly update files are the authoritative source for current code status.

2026 CMS updates affecting skin substitute codes

The 2026 rule cycle changed more about skin substitute billing than any single year before it. CMS moved payment off ASP, retired the cost tiers, and deleted a block of application codes. The MACs then withdrew the coverage policies they had spent two years preparing.

CMS gave a blunt reason for the payment change. Medicare spending on skin substitutes rose from $252 million in 2019 to more than $10 billion in 2024. The ASP-based payment method was driving that growth.

The changes that matter for a Q4156 claim are:

• Payment as an incident-to supply at $127.14 per square centimeter, effective January 1, 2026, under both the PFS non-facility rate and OPPS
• Grouping by FDA regulatory pathway, with OPPS APC 6000 for PMA products, APC 6001 for 510(k) products, and APC 6002 for Section 361 HCT/Ps
• Retirement of the high-cost and low-cost classification for every product outside the Section 351 biologic pathway
• Deletion of application codes C5271 through C5278 on December 31, 2025, leaving 15271 through 15278 in use across all settings
• Withdrawal of the diabetic foot ulcer and venous leg ulcer skin substitute LCDs on December 24, 2025, before they ever took effect

Documentation expectations did not move with the payment rules. They remain strict for skin substitute claims, and audit activity in wound care has risen rather than eased. A flat payment rate settles what Medicare pays. It does not settle whether the application was medically necessary.

Charge master teams should replace any January tier-review step with a check on FDA pathway and on the current national rate. That rate is set through the annual PFS and OPPS rulemaking, so it will move again.

How Pabau supports Q4156 skin substitute billing workflows

Wound care practices billing HCPCS code Q4156 face a documentation-intensive process. Staff measure the wound, capture prior treatment history, record the product lot number, and pair the right CPT code. All of that has to happen before the claim can go out, and manual workflows let required details slip. The result shows up later as denials and delayed reimbursement.

Practice management software like Pabau gives wound care practices one place to manage HCPCS code entry and verify code pairings. Its streamlined claims management also tracks claim status across payers.

When documentation is captured digitally at the point of care, the detail needed to support a Q4156 claim is available at billing time. That covers wound measurements, product details, and diagnosis codes, without chasing paper records.

Revenue cycle work in wound care takes more than submitting claims. It means tracking which claims are still pending and catching denials early, so a denied Q4156 claim gets appealed or corrected instead of written off.

Automated billing workflows in Pabau flag incomplete documentation before a claim is submitted. That cuts the denials caused by a missing required field.

Streamline wound care billing with Pabau

Pabau helps wound care practices capture complete documentation, manage HCPCS code entry, and submit cleaner claims. See how it works for your practice.

Book a demo

Conclusion

HCPCS code Q4156 has to line up with several other pieces on the claim. It needs the right CPT application code, a supporting ICD-10-CM code at the required specificity, and complete documentation before submission.

Payment is simpler than it was, since the 2026 incident-to supply rate replaced the annual cost-tier lookup. Medical necessity documentation still carries the same weight it always did.

Pabau helps wound care practices build consistency into their billing workflow, from structured digital encounter records through to claim submission and denial tracking. To see how it handles skin substitute billing for a practice like yours, book a demo with our team.

Continue your research

Need a structured approach to wound care billing compliance? Medical billing compliance fundamentals covers the documentation and audit readiness practices every wound care biller should know.

Wondering how clearinghouses handle HCPCS claim submissions? Medical claims clearinghouse guide explains how clearinghouses validate, route, and track HCPCS and CPT claims before they reach payers.

Looking to reduce skin substitute claim denials? Denial codes in medical billing breaks down the most common CARC denial reasons and how to resolve them.

Frequently asked questions